FDA Import Refusal AEK-9864826-2/20003/1 — Apotex Inc.
The FDA refused shipment AEK-9864826-2/20003/1 from Apotex Inc. (Canada) on Sep 14, 2026. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 14, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61JCA08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 75